These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7641510)
1. Evaluation of response to methotrexate by a functional index in juvenile chronic arthritis. Ravelli A; Viola S; Ramenghi B; Di Fuccia G; Ruperto N; Zonta L; Martini A Clin Rheumatol; 1995 May; 14(3):322-6. PubMed ID: 7641510 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis. Ravelli A; Ramenghi B; Di Fuccia G; Ruperto N; Zonta L; Martini A Acta Paediatr; 1994 Apr; 83(4):428-32. PubMed ID: 8025404 [TBL] [Abstract][Full Text] [Related]
3. Erythrocyte-methotrexate and disease activity in children treated with oral methotrexate for juvenile chronic arthritis. Kristensen K; Nielsen S; Karup Pedersen F; Zak M Scand J Rheumatol; 2000; 29(3):187-9. PubMed ID: 10898073 [TBL] [Abstract][Full Text] [Related]
4. Responsiveness of outcome measures in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. Ruperto N; Ravelli A; Falcini F; Lepore L; Buoncompagni A; Gerloni V; Bardare M; Cortis E; Zulian F; Sardella ML; Giovanni Strano C; Alessio M; Alpigiani MG; Migliavacca D; Pistorio A; Viola S; Martini A Rheumatology (Oxford); 1999 Feb; 38(2):176-80. PubMed ID: 10342633 [TBL] [Abstract][Full Text] [Related]
5. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ruperto N; Ravelli A; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano C; Alessio M; Viola S; Martini A Ann Rheum Dis; 1998 Jan; 57(1):38-41. PubMed ID: 9536821 [TBL] [Abstract][Full Text] [Related]
6. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis. Funk RS; Chan MA; Becker ML Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276 [TBL] [Abstract][Full Text] [Related]
7. Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. Ruperto N; Giannini EH Ann Rheum Dis; 1996 Jan; 55(1):73-5. PubMed ID: 8572741 [TBL] [Abstract][Full Text] [Related]
8. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis. Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357 [TBL] [Abstract][Full Text] [Related]
9. Effect of methotrexate on the temporomandibular joint and facial morphology in juvenile rheumatoid arthritis patients. Ince DO; Ince A; Moore TL Am J Orthod Dentofacial Orthop; 2000 Jul; 118(1):75-83. PubMed ID: 10893476 [TBL] [Abstract][Full Text] [Related]
10. Correlates of disablement in polyarticular juvenile chronic arthritis--a cross-sectional study. van der Net J; Prakken AB; Helders PJ; ten Berge M; Van Herwaarden M; Sinnema G; De Wilde EJ; Kuis W Br J Rheumatol; 1996 Jan; 35(1):91-100. PubMed ID: 8624631 [TBL] [Abstract][Full Text] [Related]
11. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Harel L; Wagner-Weiner L; Poznanski AK; Spencer CH; Ekwo E; Magilavy DB Arthritis Rheum; 1993 Oct; 36(10):1370-4. PubMed ID: 8216396 [TBL] [Abstract][Full Text] [Related]
13. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype. Halle F; Prieur AM Clin Exp Rheumatol; 1991; 9(3):297-302. PubMed ID: 1879091 [TBL] [Abstract][Full Text] [Related]
15. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Reiff A; Shaham B; Wood BP; Bernstein BH; Stanley P; Szer IS Clin Exp Rheumatol; 1995; 13(1):113-8. PubMed ID: 7774090 [TBL] [Abstract][Full Text] [Related]
16. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study. Leiskau C; Thon A; Gappa M; Dressler F Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955 [TBL] [Abstract][Full Text] [Related]
17. Improvements in growth parameters in children with juvenile idiopathic arthritis associated with the effect of methotrexate on disease activity. Chédeville G; Quartier P; Miranda M; Brauner R; Prieur AM Joint Bone Spine; 2005 Oct; 72(5):392-6. PubMed ID: 16087383 [TBL] [Abstract][Full Text] [Related]
18. Correlation between conventional disease activity measures in juvenile chronic arthritis. Ravelli A; Viola S; Ruperto N; Corsi B; Ballardini G; Martini A Ann Rheum Dis; 1997 Mar; 56(3):197-200. PubMed ID: 9135226 [TBL] [Abstract][Full Text] [Related]
19. Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis. Meiorin S; Filocamo G; Pistorio A; Magni-Manzoni S; Sztajnbok F; Cespedes-Cruz A; Magnani A; Ruperto N; Martini A; Ravelli A Clin Exp Rheumatol; 2009; 27(3):527-33. PubMed ID: 19604450 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]